• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国宫颈鳞状细胞癌和腺癌中高危型人乳头瘤病毒感染特征的评估

Assessment of High-Risk Human Papillomavirus Infection Characteristics in Cervical Squamous Cell Carcinoma and Adenocarcinoma in China.

作者信息

Zhuang Lijuan, Xie Xiaoyan, Wang Lihua, Weng Xiulan, Xiu Yingling, Liu Dabin, Zhong Liying

机构信息

Department of Obstetrics and Gynecology, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, 350001, People's Republic of China.

出版信息

Risk Manag Healthc Policy. 2022 Nov 2;15:2043-2055. doi: 10.2147/RMHP.S384342. eCollection 2022.

DOI:10.2147/RMHP.S384342
PMID:36348757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9637370/
Abstract

BACKGROUND

The characteristics of high-risk human papillomavirus (HR-HPV) infection in different pathological types of cervical cancer in China are unclear. The aim of this study was to evaluate HR-HPV genotypes and age stratification with cervical squamous cell carcinoma (SCC) and adenocarcinoma (ADC) in China.

MATERIALS AND METHODS

Patients diagnosed with cervical cancer by histopathology in Fujian Maternity and Child Health Hospital from January 1, 2014, to December 31, 2017, were included in this study. The HR-HPV genotype was analyzed in cervical specimens. Logistic regression was used to calculate odds ratios (ORs). All tests of statistical significance were two-sided, and the P value<0.05.

RESULTS

A total of 1,590,476 women were screened for cervical cancer, and 688 cervical cancers were detected, including 554 SCC and 93 ADC. The overall HR-HPV infection rate in SCC was higher than that in ADC (91.2% vs 81.7%, P=0.005). HPV-16 was the most prevalent genotype in SCC (70.0%) but was only 31.2% in ADC (P<0.001). However, the prevalence of HPV-18 in ADC was significantly higher than that in SCC (45.2% vs 7.0%; P<0.001). In SCC, the prevalence of HPV-16 was consistently much higher than that of HPV-18 regardless of age group. Among ADC, the prevalence of HPV-18 was higher than that of HPV-16 in women aged ≥45 years. Interestingly, in those aged <35 years, the highest prevalence was observed for HPV-16. HPV-18 infection has the highest risk of ADC (OR= 12.109; P< 0.001), and HPV-45 and HPV-51 were also found to be associated with the occurrence of ADC. However, HPV-16 infection greatly increased the risk of having histological SCC.

CONCLUSION

HPV-16 and HPV-18 infections are key risk factors for SCC and ADC. The use of HR-HPV genotyping tests in cervical cancer screening and vaccination against major HPV genotypes could reduce the incidence of cervical cancer.

摘要

背景

中国不同病理类型宫颈癌中高危型人乳头瘤病毒(HR-HPV)感染特征尚不清楚。本研究旨在评估中国宫颈鳞状细胞癌(SCC)和腺癌(ADC)中HR-HPV基因型及年龄分层情况。

材料与方法

纳入2014年1月1日至2017年12月31日在福建省妇幼保健院经组织病理学诊断为宫颈癌的患者。对宫颈标本进行HR-HPV基因型分析。采用逻辑回归计算比值比(OR)。所有统计学显著性检验均为双侧检验,P值<0.05。

结果

共筛查1,590,476名女性宫颈癌,检测出688例宫颈癌,其中554例SCC和93例ADC。SCC中HR-HPV总体感染率高于ADC(91.2%对81.7%,P = 0.005)。HPV-16是SCC中最常见的基因型(70.0%),但在ADC中仅为31.2%(P<0.001)。然而,ADC中HPV-18的患病率显著高于SCC(45.2%对7.0%;P<0.001)。在SCC中,无论年龄组,HPV-16的患病率始终远高于HPV-18。在ADC中,≥45岁女性中HPV-18的患病率高于HPV-16。有趣的是,在<35岁人群中,HPV-16患病率最高。HPV-18感染患ADC风险最高(OR = 12.109;P<0.001),且发现HPV-45和HPV-51也与ADC的发生有关。然而,HPV-16感染极大增加了组织学SCC的风险。

结论

HPV-16和HPV-18感染是SCC和ADC的关键危险因素。在宫颈癌筛查中使用HR-HPV基因分型检测以及针对主要HPV基因型进行疫苗接种可降低宫颈癌发病率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6583/9637370/fc9e66346e83/RMHP-15-2043-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6583/9637370/6d013a46c562/RMHP-15-2043-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6583/9637370/0f727d98aebb/RMHP-15-2043-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6583/9637370/fc9e66346e83/RMHP-15-2043-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6583/9637370/6d013a46c562/RMHP-15-2043-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6583/9637370/0f727d98aebb/RMHP-15-2043-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6583/9637370/fc9e66346e83/RMHP-15-2043-g0003.jpg

相似文献

1
Assessment of High-Risk Human Papillomavirus Infection Characteristics in Cervical Squamous Cell Carcinoma and Adenocarcinoma in China.中国宫颈鳞状细胞癌和腺癌中高危型人乳头瘤病毒感染特征的评估
Risk Manag Healthc Policy. 2022 Nov 2;15:2043-2055. doi: 10.2147/RMHP.S384342. eCollection 2022.
2
[Prevalence and attribution of high-risk HPV in different histological types of cervical cancer].[不同组织学类型宫颈癌中高危型人乳头瘤病毒的患病率及归因分析]
Zhonghua Fu Chan Ke Za Zhi. 2019 May 25;54(5):293-300. doi: 10.3760/cma.j.issn.0529-567x.2019.05.002.
3
The Variable Characteristics of Human Papillomavirus in Squamous Cell Carcinoma and Adenocarcinoma of Cervix in China.中国宫颈鳞癌和腺癌中人乳头瘤病毒的可变特征。
J Low Genit Tract Dis. 2018 Oct;22(4):355-361. doi: 10.1097/LGT.0000000000000408.
4
Prevalence and distribution of human papillomavirus genotypes among women with high-grade squamous intraepithelial lesion and invasive cervical cancer in Ganzhou, China.中国赣州高级别鳞状上皮内病变和浸润性宫颈癌女性中人乳头瘤病毒基因型的患病率及分布情况
J Clin Lab Anal. 2019 Mar;33(3):e22708. doi: 10.1002/jcla.22708. Epub 2018 Nov 2.
5
Cervical adenocarcinoma: moving towards better prevention.宫颈腺癌:迈向更好的预防。
Vaccine. 2011 Nov 15;29(49):9148-58. doi: 10.1016/j.vaccine.2011.09.115. Epub 2011 Oct 6.
6
Prevalence of human papillomavirus (HPV) types in cervical cancer 2003-2008 in Stockholm, Sweden, before public HPV vaccination.2003-2008 年瑞典斯德哥尔摩宫颈癌患者人乳头瘤病毒(HPV)型别流行情况,在公共 HPV 疫苗接种之前。
Acta Oncol. 2011 Nov;50(8):1215-9. doi: 10.3109/0284186X.2011.584556. Epub 2011 Jul 5.
7
Prevalence of high-risk human papillomavirus (HR-HPV) infection among women with normal and abnormal cervical cytology in Myanmar.缅甸宫颈细胞学检查正常和异常的女性中高危型人乳头瘤病毒(HR-HPV)感染的患病率
Acta Med Okayama. 2014;68(2):79-87. doi: 10.18926/AMO/52404.
8
[Distribution of human papillomavirus (HPV) among HPV positive cervical adenocarcinoma cases detected by laser capture microdissection(LCM)].[通过激光捕获显微切割(LCM)检测到的人乳头瘤病毒(HPV)阳性宫颈腺癌病例中人乳头瘤病毒(HPV)的分布情况]
Zhonghua Zhong Liu Za Zhi. 2016 Apr;38(4):277-82. doi: 10.3760/cma.j.issn.0253-3766.2016.04.007.
9
Prevalence of human papillomavirus type 16 in Sudanese women diagnosed with cervical carcinoma.在苏丹被诊断为宫颈癌的女性中16型人乳头瘤病毒的流行情况。
J Cancer Res Ther. 2019 Oct-Dec;15(6):1316-1320. doi: 10.4103/jcrt.JCRT_656_18.
10
Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.全球范围内子宫颈腺癌的人乳头瘤病毒病因及其辅助因素:对筛查和预防的意义
J Natl Cancer Inst. 2006 Mar 1;98(5):303-15. doi: 10.1093/jnci/djj067.

引用本文的文献

1
Differential impact of cervical cancer in immigrant women: a decade-long epidemiological study in the Marche Region, Italy.移民女性宫颈癌的差异影响:意大利马尔凯地区长达十年的流行病学研究
J Epidemiol Community Health. 2025 May 9;79(6):410-415. doi: 10.1136/jech-2024-222564.
2
Distribution of HPV Types in Cervical Cancer in Pakistan: Implications for Screening and Vaccination Programs.巴基斯坦宫颈癌中HPV类型的分布:对筛查和疫苗接种计划的启示
J Clin Lab Anal. 2025 Jan;39(1):e25130. doi: 10.1002/jcla.25130. Epub 2024 Dec 5.
3
Distribution of HPV types among women with HPV-related diseases and exploration of lineages and variants of HPV 52 and 58 among HPV-infected patients in China: A systematic literature review.

本文引用的文献

1
Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.勘误:2019年美国阴道镜和子宫颈病理学会基于风险的子宫颈癌筛查异常检测及癌前病变管理共识指南。
J Low Genit Tract Dis. 2021 Oct 1;25(4):330-331. doi: 10.1097/LGT.0000000000000628.
2
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.2018 年宫颈癌发病率和死亡率的估计:全球分析。
Lancet Glob Health. 2020 Feb;8(2):e191-e203. doi: 10.1016/S2214-109X(19)30482-6. Epub 2019 Dec 4.
3
Glandular cell abnormalities in cervical cytology: What has changed in this decade and what has not?
在中国 HPV 感染患者中,HPV 相关疾病患者 HPV 型别分布及 HPV52、58 型别的谱系和变异体的探索:系统文献回顾。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2343192. doi: 10.1080/21645515.2024.2343192. Epub 2024 May 14.
4
HPV genotyping of cervical histologic specimens of 61, 422 patients from the largest women hospital in China.对来自中国最大的女子医院的61422名患者的宫颈组织学标本进行人乳头瘤病毒基因分型。
Front Oncol. 2023 Mar 29;13:1161631. doi: 10.3389/fonc.2023.1161631. eCollection 2023.
宫颈细胞学中的腺细胞异常:这十年来有哪些变化,又有哪些没有变化?
Eur J Obstet Gynecol Reprod Biol. 2019 Sep;240:68-73. doi: 10.1016/j.ejogrb.2019.06.006. Epub 2019 Jun 10.
4
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
5
The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: A systematic review and meta-analysis.血清鳞状细胞癌抗原与宫颈鳞状细胞癌患者复发和生存的关系:系统评价和荟萃分析。
Gynecol Oncol. 2018 Jul;150(1):190-200. doi: 10.1016/j.ygyno.2018.03.056. Epub 2018 Mar 29.
6
The value of squamous cell carcinoma antigen (SCCa) to determine the lymph nodal metastasis in cervical cancer: A meta-analysis and literature review.鳞状细胞癌抗原(SCCa)在确定宫颈癌淋巴结转移中的价值:一项荟萃分析及文献综述。
PLoS One. 2017 Dec 11;12(12):e0186165. doi: 10.1371/journal.pone.0186165. eCollection 2017.
7
Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study.福建省中国女性宫颈病变中PCR反向斑点杂交人乳头瘤病毒基因分型检测的临床验证:一项基于医院的人群研究
J Gynecol Oncol. 2017 Sep;28(5):e50. doi: 10.3802/jgo.2017.28.e50. Epub 2017 Apr 25.
8
The variable clinicopathological categories and role of human papillomavirus in cervical adenocarcinoma: A hospital based nation-wide multi-center retrospective study across China.宫颈腺癌的临床病理分类变量及人乳头瘤病毒的作用:一项基于中国全国多中心医院的回顾性研究。
Int J Cancer. 2016 Dec 15;139(12):2687-2697. doi: 10.1002/ijc.30401. Epub 2016 Sep 14.
9
A panel of regulated proteins in serum from patients with cervical intraepithelial neoplasia and cervical cancer.一组来自宫颈上皮内瘤变和宫颈癌患者血清中的受调控蛋白质。
J Proteome Res. 2014 Nov 7;13(11):4995-5007. doi: 10.1021/pr500601w. Epub 2014 Sep 29.
10
Difference in mesothelin-binding ability of serum CA125 between patients with endometriosis and epithelial ovarian cancer.子宫内膜异位症患者与上皮性卵巢癌患者血清CA125间间皮素结合能力的差异。
Int J Cancer. 2015 Apr 15;136(8):1985-90. doi: 10.1002/ijc.29185. Epub 2014 Sep 17.